FDA Approved Medical Products for:

Acromegaly

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Octreotide
Trade Name
(Manufacturer Name)
Sandostatin LAR
(Novartis Pharmaceuticals Corporation)
Indication
The FDA has approved this product to be used in this manner.
Reduction of growth hormone and IGF-1 (somatomedin C) in acromegaly.
More Information about this product Drug Information Portal
Medline Plus Health Information

Generic Name Pasireotide
Trade Name
(Manufacturer Name)
Signifor
(Novartis Pharmaceuticals Corporation)
Indication
The FDA has approved this product to be used in this manner.
Treatment of adult patients with Cushing's disease for whom pituitary surgery is not an option or has not been curative. Treatment of patients with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option.
More Information about this product Drug Information Portal

Generic Name Lanreotide
Trade Name
(Manufacturer Name)
Somatuline® Depot (injection)
(IPSEN, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Long-term treatment of acromegalic patients who have had an inadequate response to or cannot be treated with surgery and/or radiotherapy. Treatment of patients with unresectable,well- or moderately-differentiated locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors to improve progression-free survival.
More Information about this product Drug Information Portal

Generic Name Pegvisomant
Trade Name
(Manufacturer Name)
Somavert®
(Pfizer)
Indication
The FDA has approved this product to be used in this manner.
Treatment of acromegaly in patients who have had an inadequate response to surgery and/or radiation therapy and/or other medical therapies, or for whom these therapies are not appropriate
More Information about this product Drug Information Portal